Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|July 16, 2024
Protocol for Delivery of CRISPR/dCas9 Systems for Epigenetic Editing into Solid Tumors Using Lipid Nanoparticles Encapsulating RNAEleanor A Woodward, Edina Wang, Christopher Wallis, et al.DNA and Cell Biology|February 9, 2012
Sequence-specific biosensors report drug-induced changes in epigenetic silencing in living cellsXudong Huang, Rammohan Narayanaswamy, Kathleen Fenn, et al.Epigenetics|March 16, 2012
Epigenetic reprogramming of cancer cells via targeted DNA methylationAshley G Rivenbark, Sabine Stolzenburg, Adriana S Beltran, et al.The Journal of Biological Chemistry|August 19, 2005
Development of zinc finger domains for recognition of the 5'-CNN-3' family DNA sequences and their use in the construction of artificial transcription factorsBirgit Dreier, Roberta P Fuller, David J Segal, et al.Epigenetics|January 15, 2013
Breaking through an epigenetic wall: re-activation of Oct4 by KRAB-containing designer zinc finger transcription factorsKarla Juárez-Moreno, Rafaela Erices, Adriana S Beltran, et al.Nucleic Acids Research|May 8, 2012
Targeted silencing of the oncogenic transcription factor SOX2 in breast cancerSabine Stolzenburg, Marianne G Rots, Adriana S Beltran, et al.Frontiers in Oncology|April 19, 2013
Expression of the Pluripotency Transcription Factor OCT4 in the Normal and Aberrant Mammary GlandFoteini Hassiotou, Anna R Hepworth, Adriana S Beltran, et al.Clinical Epigenetics|April 29, 2023
Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinomaAgustin Sgro, Joseph Cursons, Charlene Waryah, et al.Molecular Cancer Therapeutics|March 6, 2008
Modulation of drug resistance by artificial transcription factorsPilar Blancafort, Mario P Tschan, Sharon Bergquist, et al.Breast Cancer Research : BCR|September 29, 2011
Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factorAdriana S Beltran, Ashley G Rivenbark, Bryan T Richardson, et al.Pageof 6